|
Report from Appraisal Committee, appointed by the National Institute of Clinical Excellence (NICE) [read more]
|
|
|
|
|
|
|
|
|
|
Analysis from the Arterial Revascularisation Therapy Study II (ARTS II), sponsored by Cordis, presented at EuroPCR 2007. [read more]
|
|
|
|
|
|
|
Seven years later Peter Houghton is the world's longest-surviving LVAD patient. [read more]
|
|
|
|
|
|
|
Follow-up data for patients who received at least one Genous Bio-engineered R stent. [read more]
|
|
|
|
|
|
|
"As part of an ongoing review of our assets, we have initiated a process to explore the sale of our Cardiac Surgery and Vascular Surgery businesses..." [read more]
|
|
|
|
|
|
|
First enrollment in a major study designed to better understand appropriate anti-clotting medication therapies. [read more]
|
|
|
|
|
|
|
CUSTOM II clinical trial assessed the safety and efficacy of the investigational Custom NX drug-eluting stent (DES) system. [read more]
|
|
|
|
|
|
|
BioSTAR is designed to provide biological closure of atrial level defects using the patient's natural healing response. [read more]
|
|
|
|
|
|
|
Lovenox (Sanofi-aventis) has been shown to reduce the rate of the combined endpoint of recurrent myocardial infarction. [read more]
|
|
|
|
|
